Skip to main content
. 2010 May;5(5):805–813. doi: 10.2215/CJN.07761109

Table 2.

Associations between baseline risk factors and baseline LVMI, LVVI, and fractional shortening

Parameter Increment or Reference Category Unadjusted (β [SE]) P Adjusted, Model 1 (β [SE]) P Model 2 (β [SE]) P
LVMI
    female Male −9.28 (2.86) <0.01 −9.35 (2.86) <0.01 −10.52 (2.95) <0.01
    BMI 1.5 kg/m2 −1.02 (0.38) <0.01 −1.04 (0.39) <0.01
    SBP 13.5 mmHg 3.01 (0.90) <0.01 2.69 (0.90) <0.01
    DBP 10.0 mmHg 2.95 (1.11) <0.01 3.14 (1.13) <0.01
    Hb 0.4 g/dl −1.00 (0.46) 0.03
    serum albumin 0.1 g/dl −0.98 (0.46) 0.03 −1.17 (0.47) 0.01
    BNP 76 ng/ml −0.93 (0.12) <0.01 0.93 (0.11) <0.01 0.87 (0.13) <0.01
    Troponin T 0.005 ng/ml 0.26 (0.10) <0.01 0.20 (0.10) 0.04
LVVI
    female Male −3.60 (1.76) 0.04 −3.54 (1.76) 0.04
    hypertensive renal disease GN −7.86 (3.43) 0.02 −7.63 (3.53) 0.03 −8.01 (3.62) 0.02
    dialysis duration 1.5 months −0.58 (0.26) 0.03 −0.56 (0.30) 0.03 −0.61 (0.28) 0.04
    catheter Fistula −7.02 (2.84) 0.01 −6.22 (2.87) 0.03
    BMI 1.5 kg/m2 −1.10 (0.23) <0.01 −1.07 (0.24) <0.01 −0.81 (0.29) <0.01
    interdialytic weight gain 0.7 kg −1.22 (0.58) 0.04 −1.40 (0.59) 0.02
    BNP 76 ng/ml 0.33 (0.08) <0.01 0.33 (0.08) <0.01 0.31 (0.08) <0.01
Fractional shortening
    age 6.3 years 0.34 (0.14) 0.02 0.32 (0.14) 0.02
    female Male 2.16 (0.70) <0.01 2.11 (0.70) <0.01 2.02 (0.78) <0.01
    diabetic renal disease GN 2.41 (1.04) 0.02
    polycystic kidney disease GN 2.60 (1.31) 0.05
    BNP 76 ng/ml −0.07 (0.03) 0.04 −0.06 (0.03) 0.04 −0.08 (0.03) <.01
    Troponin T 0.005 ng/ml 0.05 (0.02) 0.04 0.06 (0.02) 0.04 0.07 (0.03) <0.01

Parameter estimates for continuous variables were computed for intervals equal to one half the interquartile range. All of the variables shown in Table 1 were considered; only those with the P < 0.05 are shown. Model 1 adjusted for age and gender; model 2 adjusted for age, gender, and variables with P < 0.05 in model 1. GN, glomerulonephritis.